The Impact of Endoscopic Third Ventriculostomy on the Management of Newly Diagnosed Hydrocephalus in Infants
Authors:
- Mohsen JavadpourMJMohsen Javadpour
- Conor MallucciCMConor Mallucci
- Andrew BrodbeltABAndrew Brodbelt
- Aprajay GolashAGAprajay Golash
- Paul MayPMPaul May
- 1 September 2001
- journal article
- clinical trial
- Published by S. Karger AG in Pediatric Neurosurgery
- Vol. 35 (3) , 131-135
Abstract
Objectives: To evaluate the role of endoscopic third ventriculostomy (ETV) as a primary treatment for hydrocephalus in children less than 1 year old and to determine its impact as a whole on the reduction of shunts necessary in a new population of hydrocephalic infants. Methods: Data were collected prospectively on 47 infants with newly diagnosed hydrocephalus of all aetiologies who were referred between 1st April 1998 and 30th September 2000. Twenty-one patients (median age 6 weeks, range 34 weeks of gestation to 10 months) underwent ETV, while the remaining 26 patients had insertion of a ventriculoperitoneal shunt. Anatomical criteria and demonstration of third ventricle outflow obstruction on preoperative magnetic resonance imaging were used to select patients for ETV. Results: There was no mortality or major morbidity following ETV. The median follow-up period was 18 (range 8–36) months. During the follow-up period, the ETV remained patent in 7 (33%) of the 21 patients. Of the 14 patients with failed ETV, 11 had insertion of a ventriculoperitoneal shunt, while 3 have undergone successful redo ETV. Therefore, in total 10 patients (48%) of the ETV group remain shunt independent. The best results were obtained in patients with congenital aqueduct stenosis with 71% (5 of 7 patients) success rate, while patients with posthaemorrhagic hydrocephalus did particularly badly with only 1 of 10 patients having a successful ETV. Overall, 10 of 47 (21%) infants with newly diagnosed hydrocephalus have avoided a shunt. Conclusions: Our results suggest that the selective use of ETV as the primary treatment in infants with hydrocephalus is safe and can lead to a reduction in the shunted population of all newly diagnosed hydrocephalic infants by up to 21%. Success of ETV is aetiology, not age dependent.Keywords
This publication has 5 references indexed in Scilit:
- Endoscopic Third Ventriculostomy: Outcome Analysis of 100 Consecutive ProceduresNeurosurgery, 1999
- Third Ventriculostomy versus Cerebrospinal Fluid Shunt as a First Procedure in Pediatric HydrocephalusPediatric Neurosurgery, 1999
- Neuroendoscopic Third Ventriculostomy in Patients Less than 1 Year OldPediatric Neurosurgery, 1998
- Endoscopic Third Ventriculostomy: An Outcome AnalysisPediatric Neurosurgery, 1998
- Third ventriculostomy: A reviewSurgical Neurology, 1997